Hematological Malignancies

Overall survival of patients > 60 years who did (n = 12) or did not (n = 22) receive whole-brain RT

Neurotoxicity-12% Relapse-58%

without WBRT

with WBRT

Neurotoxicity-75% Relapse-25%

Abrey, L. E. et al. J Clin Oncol; 18:3144-3150 2000